Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Best Practice & Research. Clinical Haematology|August 20, 2013
Disadvantages of VKA and requirements for novel anticoagulantsRaji Shameem, Jack AnsellActa Oncologica (Stockholm, Sweden)|June 11, 2014
Incidence and risk of rash to mTOR inhibitors in cancer patients--a meta-analysis of randomized controlled trialsRaji Shameem, Mario Lacouture, Shenhong WuCancer Investigation|January 31, 2015
Incidence and risk of high-grade stomatitis with mTOR inhibitors in cancer patientsRaji Shameem, Mario Lacouture, Shenhong WuActa Oncologica (Stockholm, Sweden)|May 5, 2016
Risk of hyperglycemia attributable to everolimus in cancer patients: A meta-analysisKevin Y Xu, Raji Shameem, Shenhong WuAnticancer Research|April 12, 2015
Risk of anemia attributable to everolimus in patients with cancer: a meta-analysis of randomized controlled trialsRaji Shameem, Muhammad Saad Hamid, Shenhong WuFrontiers in Pharmacology|October 25, 2013
A new paradigm shift in antithrombotic therapyAnita Pudusseri, Raji Shameem, Alex C SpyropoulosWorld Journal of Clinical Oncology|August 13, 2015
Comparative analysis of the effectiveness of abiraterone before and after docetaxel in patients with metastatic castration-resistant prostate cancerRaji Shameem, Muhammad Saad Hamid, Kevin Y Xu, et al.Journal of Cancer Epidemiology|February 17, 2015
Non-Small-Cell Lung Cancer Clinicopathologic Features and Survival Outcomes in Asian Pacific Islanders Residing in the United States: A SEER AnalysisMuhammad Saad Hamid, Raji Shameem, Khalid Gafoor, et al.Blood Neoplasia|June 2, 2025
A phase 2 study of decitabine with or without carboplatin and arsenic trioxide in patients with MDS and AMLPatricia L Kropf, Woonbok Chung, Raji Shameem, et al.Pageof 1